Similar to Mounjaro, Zepbound targets both GLP-1 and GIP receptors to enhance weight management
Scenario 1: Half the water, double the dose
The short answer is: generally, no
Research shows that most people re-gain at least a portion of their weight back after discontinuing the medication
Quick Answer: GLP-1 injections last between 24 hours and one week per dose depending on the formulation, with short-acting versions like exenatide clearing within a day and long-acting options like semaglutide remaining therapeutically active for approximately seven days
Amy Bremner, MD, breast surgical oncologist and medical director of breast surgical oncology at MemorialCare Saddleback Medical Center in Laguna Hills, CA, who wasnt involved in the study, said the findings were promising